S 272
Passed a chamber
Requires infant formula manufacturers to report confirmed positive microbial test results to the Food and Drug Administration within one business day, and requires the agency to report on infant formula supply chains and safety for five years.
Official title: Protect Infant Formula from Contamination Act
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Received
04-MAY-2026
Senate
Introduced
28-JAN-2025
Referred
28-JAN-2025
Approved by committee
15-JAN-2026
Reported
28-JAN-2026
On the calendar
28-JAN-2026
Passed
28-APR-2026
- Requires manufacturers to notify the Secretary of Health and Human Services within one business day of a confirmed positive test for a required microorganism, even if the product has already left their facility.
- Requires manufacturers to isolate affected product as the Secretary directs, stop distribution if required, and provide isolates or whole genome sequence data.
- Requires the Secretary to respond to manufacturers within one business day and to confirm within 90 days that an appropriate investigation and corrective action are underway.
- Requires a progress report within 180 days on the FDA's 2025 infant formula supply strategy, quarterly supply chain reports for five years, and supply adequacy reports at 1, 3, and 5 years.
Covers an older version. The newest CRS summary describes the bill as of "Introduced in Senate" (28-JAN-2025); the text has changed since (Engrossed in Senate, 28-APR-2026).
CRS is the Library of Congress's nonpartisan research office. Read it on congress.govHealth
■ 6 D■ 3 R
3 Republicans